188 related articles for article (PubMed ID: 28711515)
21. Truncal and leg fat associations with metabolic risk factors among Chinese adults.
Yang M; Lin J; Ma X; Zhu C; Wei C; Wang L; Jiao J; Zhu S
Asia Pac J Clin Nutr; 2016 Dec; 25(4):798-809. PubMed ID: 27702723
[TBL] [Abstract][Full Text] [Related]
22. Visceral Fat Is an Independent Predictor of Cerebral Microbleeds in Neurologically Healthy People.
Kwon HM; Park JH; Park JH; Jeong HY; Lim JS; Jeong HG; Shin DW; Yun JM; Lee H
Cerebrovasc Dis; 2016; 42(1-2):90-6. PubMed ID: 27070832
[TBL] [Abstract][Full Text] [Related]
23. Measurement site and the association between visceral and abdominal subcutaneous adipose tissue with metabolic risk in women.
Kuk JL; Church TS; Blair SN; Ross R
Obesity (Silver Spring); 2010 Jul; 18(7):1336-40. PubMed ID: 19910940
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome associates with left atrial dysfunction.
Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):727-734. PubMed ID: 29764718
[TBL] [Abstract][Full Text] [Related]
25. Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects.
Oliveira AL; Azevedo DC; Bredella MA; Stanley TL; Torriani M
Obesity (Silver Spring); 2015 Feb; 23(2):286-9. PubMed ID: 25522219
[TBL] [Abstract][Full Text] [Related]
26. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.
Klimcáková E; Roussel B; Márquez-Quiñones A; Kovácová Z; Kováciková M; Combes M; Siklová-Vítková M; Hejnová J; Srámková P; Bouloumié A; Viguerie N; Stich V; Langin D
J Clin Endocrinol Metab; 2011 Jan; 96(1):E73-82. PubMed ID: 21047918
[TBL] [Abstract][Full Text] [Related]
27. Association of Vitamin E Levels with Metabolic Syndrome, and MRI-Derived Body Fat Volumes and Liver Fat Content.
Waniek S; di Giuseppe R; Plachta-Danielzik S; Ratjen I; Jacobs G; Koch M; Borggrefe J; Both M; Müller HP; Kassubek J; Nöthlings U; Esatbeyoglu T; Schlesinger S; Rimbach G; Lieb W
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057829
[TBL] [Abstract][Full Text] [Related]
28. Expression of MYD88 in Adipose Tissue of Obese People: Is There Some Role in the Development of Metabolic Syndrome?
Cuevas AM; Lazo M; Zuñiga I; Carrasco F; Potter JJ; Alvarez V; Berry M; Maluenda F; Ferrario M; Clark JM
Metab Syndr Relat Disord; 2017 Mar; 15(2):80-85. PubMed ID: 28075222
[TBL] [Abstract][Full Text] [Related]
29. Biological Determinants of Metabolic Syndrome in Visceral and Subcutaneous Adipose Tissue from Severely Obese Women.
Osorio-Conles Ó; Vega-Beyhart A; Ibarzabal A; Balibrea JM; Vidal J; de Hollanda A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216509
[TBL] [Abstract][Full Text] [Related]
30. Differential associations of abdominal visceral, subcutaneous adipose tissue with cardiometabolic risk factors between African and European Americans.
Liu J; Coady S; Carr JJ; Hoffmann U; Taylor HA; Fox CS
Obesity (Silver Spring); 2014 Mar; 22(3):811-8. PubMed ID: 23408700
[TBL] [Abstract][Full Text] [Related]
31. Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population.
Kim S; Cho B; Lee H; Choi K; Hwang SS; Kim D; Kim K; Kwon H
Diabetes Care; 2011 Feb; 34(2):504-6. PubMed ID: 21228245
[TBL] [Abstract][Full Text] [Related]
32. Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET/CT.
Tahara N; Yamagishi S; Kodama N; Tahara A; Honda A; Nitta Y; Igata S; Matsui T; Takeuchi M; Kaida H; Kurata S; Abe T; Fukumoto Y
J Clin Endocrinol Metab; 2015 May; 100(5):E739-47. PubMed ID: 25695885
[TBL] [Abstract][Full Text] [Related]
33. Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein.
Faber DR; Moll FL; Vink A; van der Waal C; Kalkhoven E; Schipper HS; Hajer GR; Monajemi H; Visseren FL
Int J Obes (Lond); 2012 Aug; 36(8):1078-85. PubMed ID: 22064157
[TBL] [Abstract][Full Text] [Related]
34. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
[TBL] [Abstract][Full Text] [Related]
35. Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.
Kim LJ; Nalls MA; Eiriksdottir G; Sigurdsson S; Launer LJ; Koster A; Chaves PH; Jonsdottir B; Garcia M; Gudnason V; Harris TB;
Obesity (Silver Spring); 2011 Jun; 19(6):1265-71. PubMed ID: 21183935
[TBL] [Abstract][Full Text] [Related]
36. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
Lee CG; Lee JK; Kang YS; Shin S; Kim JH; Lim YJ; Koh MS; Lee JH; Kang HW
Am J Gastroenterol; 2015 Feb; 110(2):310-9. PubMed ID: 25583325
[TBL] [Abstract][Full Text] [Related]
37. Circulating selenoprotein P levels in relation to MRI-derived body fat volumes, liver fat content, and metabolic disorders.
di Giuseppe R; Koch M; Schlesinger S; Borggrefe J; Both M; Müller HP; Kassubek J; Jacobs G; Nöthlings U; Lieb W
Obesity (Silver Spring); 2017 Jun; 25(6):1128-1135. PubMed ID: 28474510
[TBL] [Abstract][Full Text] [Related]
38. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Elguezabal Rodelo RG; Porchia LM; Torres-Rasgado E; López-Bayghen E; Gonzalez-Mejia ME
PLoS One; 2024; 19(2):e0298662. PubMed ID: 38394065
[TBL] [Abstract][Full Text] [Related]
39. The Ratio Between Visceral and Subcutaneous Abdominal Fat Assessed by Computed Tomography Is an Independent Predictor of Mortality and Cardiac Events.
Ladeiras-Lopes R; Sampaio F; Bettencourt N; Fontes-Carvalho R; Ferreira N; Leite-Moreira A; Gama V
Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):331-337. PubMed ID: 27765543
[TBL] [Abstract][Full Text] [Related]
40. Performance of abdominal bioelectrical impedance analysis and comparison with other known parameters in predicting the metabolic syndrome.
Mousa U; Kut A; Bozkus Y; Cicek Demir C; Anil C; Bascil Tutuncu N
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):391-6. PubMed ID: 23696479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
